These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8742803)

  • 1. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular modeling of N-isopropyl lisergamides analogous to LSD using molecular mechanics and quantum mechanical calculations].
    Cordero de Troconis MI; Pfaff R; Nichols D
    Acta Cient Venez; 1997; 48(2):85-90. PubMed ID: 9567327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 4. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of serotonin 5-HT2 receptors.
    Shih JC; Chen K; Gallaher TK
    NIDA Res Monogr; 1994; 146():284-97. PubMed ID: 8742804
    [No Abstract]   [Full Text] [Related]  

  • 6. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    Appel JB; Cunningham KA
    Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 11. Do classical hallucinogens act as 5-HT2 agonists or antagonists?
    Glennon RA
    Neuropsychopharmacology; 1990; 3(5-6):509-17. PubMed ID: 2078284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z; Podvalová I; Vojtĕchovský M
    Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
    [No Abstract]   [Full Text] [Related]  

  • 13. Hallucinogens acting at 5-HT receptors: toward a mechanistic understanding at atomic resolution.
    Weinstein H; Zhang D; Ballesteros JA
    NIDA Res Monogr; 1994; 146():241-62. PubMed ID: 8742802
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of opioid and LSD receptors: structural activity relationship implications.
    Martin WR
    NIDA Res Monogr; 1978; (22):60-9. PubMed ID: 30913
    [No Abstract]   [Full Text] [Related]  

  • 15. [LSD-25 and UML decrease the levels of 5-hydroxyindoleacetic acid in the brain of rat].
    Torre M; Bogetto F; Torre E
    Boll Soc Ital Biol Sper; 1976 Nov; 52(21):1835-7. PubMed ID: 1026256
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
    Nichols DE
    J Theor Biol; 1976 Jun; 59(1):167-77. PubMed ID: 7711
    [No Abstract]   [Full Text] [Related]  

  • 17. LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    AMA Arch Gen Psychiatry; 1960 Apr; 2():390-407. PubMed ID: 14415046
    [No Abstract]   [Full Text] [Related]  

  • 18. LSD and JB 318: a comparison of two hallucinogens. III. Qualatative analysis and summary of findings.
    LEBOVITS BZ; VISOTSKY HM; OSTEFELD AM
    Arch Gen Psychiatry; 1962 Jul; 7():39-45. PubMed ID: 14463342
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonergic mechanisms of hallucinogenic drug effects.
    Heym J; Jacobs BL
    Monogr Neural Sci; 1987; 13():55-81. PubMed ID: 2891030
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.